Roche survey: Many millennial women skipping cervical cancer screenings
Indianapolis-based Roche Diagnostics said while the survey was conducted in Europe, its implications are global and reflect challenges in the United States.
Roche Diagnostics
-
Roche gets FDA clearance for test of emerging cardiovascular disease risk factor
Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.
Read More -
Roche data shows simple blood test can help determine if someone has Alzheimer’s
Roche is developing the tests in partnership with Indianapolis-based Eli Lilly and Co. Earlier this year, the U.S. Food and Drug Administration granted a breakthrough device designation to the product.
Read More -
Roche Diagnostics names new North American chief
Brad Moore succeeds Matt Sause, who was appointed CEO of Roche Diagnostics globally in October.
Read More -
Chief of Roche Diagnostics North America leaving Indy for larger corporate job
Matt Sause, president and CEO of Roche Diagnostics North America since 2019, has been named CEO of Roche Diagnostics and a member of the corporate executive committee. He will relocate to the parent company’s offices in Basel, Switzerland.
Read More
Articles
Roche receives FDA clearance for Alzheimer’s blood test
The test—developed in collaboration with Eli Lilly and Co.—does not diagnose Alzheimer’s but is designed to rule out the presence of the disease’s pathology early on, or indicate further diagnostics are needed.
Roche’s FDA-approved vitamin D test clears way for diagnostic growth
The new vitamin D test, to be distributed from the Swiss-based company’s Indianapolis hub, is the first such test using a mass spectrometry-based system to receive regulatory approval in the U.S.
Trump plans hefty tax on imported drugs, risking higher prices, shortages
The threat comes as Trump also pressures drugmakers to lower prices of pharmaceuticals in the United States.
Indy health care workers take hands-on approach to ‘food as medicine’ concept
At the 5,000-square-foot Roche Community Garden, Roche employees grow tomatoes, strawberries, watermelons and a variety of peppers to be provided to low-income patients.
Roche to test whether new drug can prevent Alzheimer’s
The new late-stage study will focus on people who are at risk of cognitive decline.
UPDATE: Roche Diagnostics to invest up to $550M in Indianapolis, adding hundreds of local jobs
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
Roche picks Indiana for new plant, expanded operations as part of $50B investment in United States
Roche said Indiana would receive a new manufacturing facility for continuous glucose monitoring and expansion and upgrades at existing pharmaceutical, diagnostics and distribution operations.
Roche Diagnostics hopes new self-collection HPV test will expand screening for cervical cancer risk
The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of access, past trauma or embarrassment.
Roche has more than five weight-loss companion medicines, CEO says
The the Swiss drugmaker will face off in the obesity area with leaders Novo Nordisk A/S and Indianapolis-based Eli Lilly and Co.
Lilly, Roche to get expedited FDA review for blood test to diagnose Alzheimer’s disease
Roche and Lilly said they believe the test could play an important role in improving access to early and accurate Alzheimer’s diagnosis.
BioCrossroads names Vince Wong as new CEO of Indy life sciences group
Wong’s appointment comes just a few weeks after BioCrossroads released a report warning that Indiana’s life-science sector is starting to lag the nation in growth and market share and will require a focused effort to stay competitive.
Roche to buy bowel drugmaker Telavant for $7.1 billion
Roche has come under pressure to improve its pipeline with medicines it can commercialize soon as a windfall of revenue from products used in the COVID-19 pandemic comes to an end.
Roche executive sues company for discrimination after losing job in restructuring
Brigitte Fernandes is suing Roche for sex discrimination and national origin discrimination. A Roche spokesman declined to comment, citing pending litigation.
CORRECTED: Roche gets city’s OK to project messages on side of north-side HQ building
In a statement to IBJ, Roche said it hopes to display “supportive and inspiring messages” visible from I-69 as part of a new corporate initiative.
Roche lands $340M to make rapid antigen tests in Indianapolis
The contract is part of the U.S. government’s effort to double its procurement of rapid COVID-19 tests to be delivered for free to Americans through a forthcoming federal website.
In a lockdown, Roche pushes ahead with new, different diagnostic tests
Matthew Sause took the helm of the 4,500-person Roche Diagnostics’ North American operations in Indianapolis in November 2019—just four months before the World Health Organization declared a pandemic and much of the planet went into lockdown.
Roche Diagnostics whistleblower wins $3.6M in settlement agreement
Crystal Derrick, who was a national account manager in Roche’s diabetes division, had accused the company of illegally paying insurance company Humana Inc. for access to certain formularies.
Roche’s COVID-19 antibody test gets emergency FDA approval
Roche Diagnostics’ North American headquarters in Indianapolis will be the shipping and distribution hub for all tests distributed in the United States, the company said.
Roche begins shipping emergency-approved COVID-19 tests across country
Indianapolis-based Roche Diagnostics said Monday that it has begun shipping an initial order of 400,000 COVID-19 test kits to a network of more than 30 hospital and laboratories.